Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Telcian, L. Stanciu, S. Johnston (London, United Kingdom). Late Breaking Abstract: Cathelicidin has direct anti-rhinoviral activity. Eur Respir J 2010; 36: Suppl. 54, 304

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract: Expression of S100A4 in COPD Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Late Breaking Abstract - Immunomodulatory and clinical effects of RIPK1 inhibitor SAR443122 in patients with severe COVID-19 Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Late Breaking Abstract - Promoting physical activity by the Respiratory Nurses Source: Virtual Congress 2021 – Nursing perspective during the COVID-19 pandemic Year: 2021 Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021 Late Breaking Abstract: Activation of the WNT/β-catenin pathway attenuates experimental emphysema Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Late Breaking Abstract - Efficacy of DPP1 inhibition with brensocatib in subgroups of patients with bronchiectasis- the WILLOW study Source: Virtual Congress 2020 – ALERT: Infection in adults and children Year: 2020 Late Breaking Abstract - WEAning From NonInvasive Ventilation – ‘WEANIV’ Study Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation Year: 2020 Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Late Breaking Abstract - ACE2 Overexpression Modulates Nicotine Receptors In Cell Type Specific Manner: Possible Relevance In Covid-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 Late Breaking Abstract - Title: Air-born allergens modulate the immunological lung microenvironment. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Late Breaking Abstract - A Pilot study of a novel Endoscopic Lung Volume Reduction device Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Mapping fibroblast activity in IPF– the instructive lung ECM Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Late Breaking Abstract - BBT-877, a Potent Autotaxin Inhibitor in Clinical Development to Treat Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Late Breaking Abstract - Organoids and lung-on-chip to study SARS-CoV-2-mediated lung injury Source: Virtual Congress 2020 – Covering COVID - the best abstracts Year: 2020 Late Breaking Abstract - Anti-inflammatory and anti-fibrotic effect of novel, pan-PDE inhibitors in human bronchial epithelial cells Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Late Breaking Abstract - Elevated NETosis and migration but impaired anti-microbial responses by COVID-19 neutrophils Source: Virtual Congress 2021 – Acute COVID - 19 Year: 2021 Late Breaking Abstract - Novel mesenchymal pathways that initiate emphysema Source: International Congress 2018 – Intercellular communication in tissue remodelling Year: 2018 Late Breaking Abstract - Anti-inflammatory activity of novel transtilbene sulfonamide analogues as potential novel therapeutic agents for inflammatory lung disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Late Breaking Abstract - Implications of new PH definition for CTEPD Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Late Breaking Abstract - Pharmacological characterization of T cell-induced broncho-constriction in vitro and in vivo Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018